Monday, August 31, 2026 SourcesAbout🌓
🇨🇦 CA ▾
Américas🇧🇷 Brasil🇺🇸 United States🇨🇦 Canada🇻🇪 Venezuela🇲🇽 México🇦🇷 Argentina
Europa🇫🇷 France🇬🇧 United Kingdom🇪🇸 España🇵🇹 Portugal🇩🇪 Deutschland🇷🇺 Россия
Ásia-Pacífico🇯🇵 日本🇦🇺 Australia🇮🇳 India🇰🇷 대한민국🇨🇳 中国
África🇿🇦 South Africa
BREAKING
› 4 teens charged in airsoft pistol confrontation at Lethbridge mall› 3 byelections test Carney government's popularity as U.S. trade war heats up› Nearly 400 physicians interested in joining dual practice system: Alberta government› Trump ballroom construction can continue amid legal challenges, U.S. Supreme Court rules› Montreal woman searches for cat last seen at Toronto Pearson airport› Vehicle break-ins increasing across Edmonton, especially in west end and downtown› Elections Alberta receives 225K requests for referendum mail-in ballots› Wawrinka’s Grand Slam career ends with loss to Berrettini at US Open› Langley man jailed for almost 12 years after police bust drugs and weapons operation› Edmonton looking to improve snow and ice clearing policy› 4 teens charged in airsoft pistol confrontation at Lethbridge mall› 3 byelections test Carney government's popularity as U.S. trade war heats up› Nearly 400 physicians interested in joining dual practice system: Alberta government› Trump ballroom construction can continue amid legal challenges, U.S. Supreme Court rules› Montreal woman searches for cat last seen at Toronto Pearson airport› Vehicle break-ins increasing across Edmonton, especially in west end and downtown› Elections Alberta receives 225K requests for referendum mail-in ballots› Wawrinka’s Grand Slam career ends with loss to Berrettini at US Open› Langley man jailed for almost 12 years after police bust drugs and weapons operation› Edmonton looking to improve snow and ice clearing policy
Business

Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update

Financial Post ·

VANCOUVER, British Columbia, Aug.

31, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial results for the three and six months ended June 30, 2026 (“Q2 2026” and “YTD 2026”, respectively), and provided an update on recent corporate developments.

Read More

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

More from Financial Post

See all ›

Argo Reports Q2 2026 Results: 680% Revenue Growth

Financial Post · 1 h ago

Marten Falls First Nation and Bird Construction Expand Piinahzii LP Partnership Agreement to Include Construction of the Marten Falls Community Access Road

Financial Post · 2 h ago

Ares Closes Fifth Japan Logistics Real Estate Development Fund at ¥612 Billion (US$4 Billion), Hitting Hard Cap

Financial Post · 2 h ago

Strategic Combination of ITC Infotech and Happiest Minds Technologies to Create a Scaled, Future-Ready, AI-First Global Technology Services Enterprise with US$ 1 Billion Revenue by FY28[1]

Financial Post · 3 h ago

More in Business

See all ›

Argo Reports Q2 2026 Results: 680% Revenue Growth

Financial Post · 1 h ago

Marten Falls First Nation and Bird Construction Expand Piinahzii LP Partnership Agreement to Include Construction of the Marten Falls Community Access Road

Financial Post · 2 h ago

Ares Closes Fifth Japan Logistics Real Estate Development Fund at ¥612 Billion (US$4 Billion), Hitting Hard Cap

Financial Post · 2 h ago

Strategic Combination of ITC Infotech and Happiest Minds Technologies to Create a Scaled, Future-Ready, AI-First Global Technology Services Enterprise with US$ 1 Billion Revenue by FY28[1]

Financial Post · 3 h ago

Patagonia Gold Quarter 2 2026 Financial Results

Financial Post · 3 h ago

News of the day: Banks eye major projects, U.S. dollar bear market, investing advice, merit-based pay increases, salvaging Canada-U.S. free trade and more

Financial Post · 3 h ago